Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Aselage Steve
Relationship:   Director
City:   Fremont
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   293,421    

Indirect Shares

  22,000      
Direct Value   $6,950,507    

Indirect Value

  $160,840      
Total Shares   315,421      
Total Value   $7,111,347      


Cti Biopharma Corporation
 $219,369 Biomarin Pharmaceutical Inc
 $5,231,829 Travere Therapeutics, Inc
 $1,090,139 Biocryst Pharmaceuticals Inc
 $409,170 Cti Biopharma Corporation
 $219,369 Biomarin Pharmaceutical Inc
 $5,231,829 Travere Therapeutics, Inc
 $1,090,139 Biocryst Pharmaceuticals Inc
 $409,170
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    5   
    5    

     Stock price went up :

    1   
    3    
     Stock price went down :
    4   
    2    
   
     Gain/Loss Ratio :
   0.0   
   1.5   
     Percentage Gain/Loss :
   -23.4%
 62.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cti Biopharma Corporation CTIC EVP, Global Commercial... 2005-06-30 24,133 2004-08-03 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Business Of... 2012-07-02 59,030 2006-04-28 0    Premium*  
            Travere Therapeutics, Inc TVTX Director 2022-05-11 146,919 2021-11-05 19,500    Premium*  
            Acer Therapeutics Inc ACER Director 2023-11-17 0 2017-09-19 0    Premium*  
            Biocryst Pharmaceuticals Inc BCRX Director 2024-05-24 63,339 2024-05-24 2,500    Premium*  
* Premium Members only  

Records found :    170         Free Registration Required For Full Results.    Limit: 25

Download
  Page 5 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2016-11-22 4 S $21.30 $68,160 D/D (3,200) 240,556 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev.   •       –      –    2007-09-14 4 OE $7.16 $71,600 D/D 10,000 14,895 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2014-11-21 4 B $8.50 $73,950 D/D 8,700 371,756 2.81 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Ops   •       –      –    2006-11-29 4 S $17.23 $86,150 D/D (5,000) 2,829 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2017-06-14 4 S $17.85 $89,250 D/D (5,000) 245,556 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-08-31 4 OE $8.70 $104,400 D/D 12,000 257,883 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2016-11-21 4 S $21.00 $105,000 D/D (5,000) 243,756 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-11-02 4 AS $30.00 $105,000 I/I (3,500) 19,500 0 %
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Ops   •       –      –    2007-02-14 4 OE $7.16 $107,400 D/D 15,000 17,829 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-04 4 S $21.50 $107,500 D/D (5,000) 50,361 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2007-10-01 4 AS $24.90 $125,471 D/D (5,000) 4,895 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-11-14 4 AS $23.63 $131,735 D/D (5,550) 258,833 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-12-21 4 AS $21.69 $134,829 D/D (6,188) 259,772 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-11-15 4 AS $24.21 $134,969 D/D (5,550) 253,283 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-12-20 4 AS $21.97 $135,958 D/D (6,188) 265,960 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-05 4 S $21.95 $140,831 D/D (6,416) 43,945 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev.   •       –      –    2008-05-06 4 OE $7.16 $142,348 D/D 12,205 48,665 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2007-08-10 4 OE $7.16 $143,200 D/D 20,000 24,895 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev.   •       –      –    2008-05-02 4 S $37.75 $143,450 D/D (3,800) 44,865 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2020-12-15 4 S $26.02 $144,385 D/D (5,549) 196,667 0 %
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-11-01 4 AS $29.48 $147,400 I/I (5,000) 23,000 0 %
ACER Acer Therapeutics Inc Director   –       •      –    2020-07-24 4 B $3.50 $157,500 D/D 45,000 63,905 2.39 %
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-05-25 4 OE $17.33 $159,037 D/D 9,177 53,155 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-03-17 4 OE $16.23 $162,300 D/D 10,000 206,667 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-04-16 4 OE $16.23 $162,300 D/D 10,000 198,940 0 -

  170  Records found
  1   2   3   4   5  6   7      
  Page 5 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed